Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +52.8% | -5404.6% | 2 / 3 | +68.1% | +7.72 pp | +46.33 pp | -119.8% | 12.69 | — | 2,2 | +68,1% | −0,4 | +52,8% | — | -0.26 | — |
| Pts | 8 | 0 | 8 | 12 | 12 | 12 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 3.100 (close price on 2026-10-19)EPS (TTM): −5.515,9
Financial charts
1.Revenue & growth
VND bn2,21Q2/26
1.Revenue & growth
VND bn2,21Q2/26
2.Profit & growth
VND bn-0,40Q2/26
3.Profit mix (Penman)
VND bn-6,62Q2/26
4.Margins & cost structure
%-15.7%Q2/26
5.Returns & cash cycle
% · days-9.7%Q2/26
6.Earnings quality & cash
VND bn-1,03Q2/26
7.Asset structure
VND bn65,4Q2/26
8.Funding & debt health
VND bn · times65,4Q2/26
9.Revenue backlog
VND bn1,18Q2/26
10.Valuation
times · %-0,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-333Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-16316%
averaged over 1 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26